Erratum: STIM1 and STIM2 protein deficiency in T lymphocytes underlies development of the exocrine gland autoimmune disease, Sjögren 's syndrome (Proceedings of the National Academy of Sciences of the United States of America (2012) 109, 36 (14544-14549) DOI: 10.1073/pnas.1207354109);STIM1 and STIM2 protein deficiency in T lymphocytes underlies development of the exocrine gland autoimmune disease, Sjögren's syndrome

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 36, 2012, Pages 14544-14549

  Cheng, Kwong Tai ^a   Alevizos, Ilias ^a   Liu, Xibao ^a   Swaim, Wiliam D ^a   Yin, Hongen ^b   Feske, Stefan ^c   Oh hora, Masatsugu ^d,e   Ambudkar, Indu S ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Immunology; Knockout mice; Orai1; Rheumatology

Indexed keywords

STROMAL INTERACTION MOLECULE 1; STROMAL INTERACTION MOLECULE 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CALCIUM TRANSPORT; CONTROLLED STUDY; DISEASE SEVERITY; EXOCRINE GLAND; FEMALE; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SALIVARY GLAND; SJOEGREN SYNDROME; STORE OPERATED CALCIUM ENTRY; T LYMPHOCYTE;

MUS;

EID: 84866000332     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1217344109     Document Type: Erratum

References (41)

1. Putney JW, Jr. (1986) A model for receptor-regulated calcium entry. Cell Calcium 7: 1-12.
2. Lewis RS (2001) Calcium signaling mechanisms in T lymphocytes. Annu Rev Immunol 19:497-521.
3. Feske S (2007) Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol 7:690-702.
4. Hogan PG, Rao A (2007) Dissecting ICRAC, a store-operated calcium current. Trends Biochem Sci 32:235-245. (Pubitemid 46694334)
5. Oh-hora M, Rao A (2008) Calcium signaling in lymphocytes. Curr Opin Immunol 20: 250-258.
6. 2+ store to the plasma membrane. Nature 437:902-905. (Pubitemid 41486767)
7. 2+ store depletion. Proc Natl Acad Sci USA 104:9301- 9306.
8. Hogan PG, Lewis RS, Rao A (2010) Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. Annu Rev Immunol 28:491-533.
9. Feske S, et al. (2006) A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441:179-185.
10. Abdullaev IF, et al. (2008) Stim1 and Orai1 mediate CRAC currents and store-operated calcium entry important for endothelial cell proliferation. Circ Res 103:1289-1299.
11. Feske S, Picard C, Fischer A (2010) Immunodeficiency due to mutations in ORAI1 and STIM1. Clin Immunol 135:169-182.
12. Oh-Hora M, et al. (2008) Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance. Nat Immunol 9:432-443.
13. Delaleu N, Jonsson MV, Appel S, Jonsson R (2008) New concepts in the pathogenesis of Sjögren's syndrome. Rheum Dis Clin North Am 34:833-845, vii.
14. Theander E, et al. (2006) Lymphoma and other malignancies in primary Sjögren's syndrome: A cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 65:796-803. (Pubitemid 43799181)
15. Hansen A, Lipsky PE, Dörner T (2005) Immunopathogenesis of primary Sjögren's syndrome: Implications for disease management and therapy. Curr Opin Rheumatol 17:558-565. (Pubitemid 41527815)
16. Nikolov NP, Illei GG (2009) Pathogenesis of Sjögren's syndrome. Curr Opin Rheumatol 21:465-470.
17. Cha S, Peck AB, Humphreys-Beher MG (2002) Progress in understanding autoimmune exocrinopathy using the non-obese diabetic mouse: An update. Crit Rev Oral Biol Med 13:5-16. (Pubitemid 34792757)
18. Delaleu N, Nguyen CQ, Peck AB, Jonsson R (2011) Sjögren's syndrome: studying the disease in mice. Arthritis Res Ther 13:217.
19. Oak JS, et al. (2006) Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase. Proc Natl Acad Sci USA 103:16882-16887. (Pubitemid 44737347)
20. Sharma R, Deshmukh US, Zheng L, Fu SM, Ju ST (2009) X-linked Foxp3 (Scurfy) mutation dominantly inhibits submandibular gland development and inflammation respectively through adaptive and innate immune mechanisms. J Immunol 183: 3212-3218.
21. Sharma R, et al. (2006) Novel animal models for Sjögren's syndrome: Expression and transfer of salivary gland dysfunction from regulatory T cell-deficient mice. J Autoimmun 27:289-296. (Pubitemid 46199126)
22. De Paiva CS, et al. (2010) Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice. Rheumatology (Oxford) 49:246-258.
23. Salam MA, et al. (2004) E2f1 mutation induces early onset of diabetes and Sjögren's syndrome in nonobese diabetic mice. J Immunol 173:4908-4918. (Pubitemid 39387772)
24. Tang Q, et al. (2008) Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28:687-697.
25. Wahren M, Skarstein K, Blange I, Pettersson I, Jonsson R (1994) MRL/lpr mice produce anti-Ro 52,000 MW antibodies: Detection, analysis of specificity and site of production. Immunology 83:9-15. (Pubitemid 24285391)
26. Skarstein K, Wahren M, Zaura E, Hattori M, Jonsson R (1995) Characterization of T cell receptor repertoire and anti-Ro/SSA autoantibodies in relation to sialadenitis of NOD mice. Autoimmunity 22:9-16. (Pubitemid 26092810)
27. Picard C, et al. (2009) STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N Engl J Med 360:1971-1980.
28. Gwack Y, et al. (2008) Hair loss and defective T- and B-cell function in mice lacking ORAI1. Mol Cell Biol 28:5209-5222.
29. Vig M, et al. (2008) Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels. Nat Immunol 9:89-96. (Pubitemid 350286208)
30. Wu Y, et al. (2006) FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126:375-387. (Pubitemid 44092960)
31. Sakaguchi S, Sakaguchi N (1988) Thymus and autoimmunity. Transplantation of the thymus from cyclosporin A-treated mice causes organ-specific autoimmune disease in athymic nude mice. J Exp Med 167:1479-1485.
32. Alevizos I, Illei GG (2010) MicroRNAs as biomarkers in rheumatic diseases. Nat Rev Rheumatol 6:391-398.
33. Gallo A, Tandon M, Alevizos I, Illei GG (2012) The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS ONE 7:e30679.
34. 2+ entry through ORAI1 is critical for T cell-mediated autoimmunity and allograft rejection. J Immunol 185:5845-5858.
35. Anderson JT, Cornelius JG, Jarpe AJ, Winter WE, Peck AB (1993) Insulin-dependent diabetes in the NOD mouse model. II. Beta cell destruction in autoimmune diabetes is a TH2 and not a TH1 mediated event. Autoimmunity 15:113-122. (Pubitemid 23276006)
36. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198: 1875-1886. (Pubitemid 38032120)
37. McCartney-Francis NL, et al. (1996) Autoimmune Sjögren's syndrome-like lesions in salivary glands of TGF-beta1-deficient mice are inhibited by adhesion-blocking peptides. J Immunol 157:1306-1312. (Pubitemid 126449648)
38. Li X, et al. (2007) T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjögren's syndrome. J Rheumatol 34:2438-2445. (Pubitemid 350230668)
39. Liu MF, Lin LH, Weng CT, Weng MY (2008) Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sjögren's syndrome. Lupus 17:34-39.
40. Fuchs S, et al. (2012) Antiviral and regulatory T cell immunity in a patient with stromal interaction molecule 1 deficiency. J Immunol 188:1523-1533.
41. Matsumoto M, et al. (2011) The calcium sensors STIM1 and STIM2 control B cell regulatory function through interleukin-10 production. Immunity 34:703-714.